We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Andexanet Alfa Is Associated With Lower In-Hospital Mortality Compared to 4-Factor Prothrombin Complex Concentrate in Patients With Factor Xa Inhibitor–Related Major Bleeding
Paul P. Dobesh, PharmD, FACC, FAHA, FCCP, BCPS, BCCP
Life-Threatening Bleeding in the Anticoagulated Patient: Real World Evidence
Natalie Kreitzer, MD, MS
ANNEXa-I: Recent Advances in the Treatment of Intracranial Hemorrhage (ICH)
GI Bleeding and DOACs: Consensus Panel Findings
Gregory J. Fermann, MD
Summary of Real-World Data for Treatment of Oral Factor Xa-Related Major Bleeding
Clinical Implications of ANNEXa-I on the Management of ICH for Neurointensivists and Emergency Physicians
W. Brian Gibler, MD, FACEP, FACC, FAHA
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education